RE: SP should be £1.10 at least MM's taking the **** not letting it fly12 Mar 2021 12:29
Davde, there needs to be more transparency about their contracting that's for sure. It's frustrating because if things were done properly we would know exactly where we stand. But look at the size of the Innova contracts. Billions have gone to them. The budget going forward is £8 billion to cover a reported 260 million lateral flow tests (280 million less 20 million to Surescreen recently). So shy of £20.00 a test. That's for lateral flow tests according to bidstats.
RE: SP should be £1.10 at least MM's taking the **** not letting it fly12 Mar 2021 12:17
Hi Flashy, bidstats is showing £500 million to Surescreen and gov.uk put out a press release from the DHSC on 8th February saying that they had bought 20 million from Surescreen. It was covered in the FT at the time. Best, Tricky. GLA.
RE: SP should be £1.10 at least MM's taking the **** not letting it fly12 Mar 2021 12:02
It's a psychological barrier. And folks not wanting to lose their low average. Contracts are indicating that the government are paying £25.00 a test. Surescreen contract for 20 million for £500 million. ODX are manufacturing someone else's test so it won't be that much. But that is 5 x the reported agreement for the ABC19 test. We could easily be looking at £8-10.00 a test. I bought at £1.00 on February 11th. Low average is long gone. More money in. More money to be made.
We're just going to get loads of these contract publications now. They didn't publish at the time they were awarded. And they have to publish them because they lost the judicial review. It's interesting to see the size of the contracts awarded. Bodes well.
We have some very good indicators where this is going. Old awards for £700 million are being published (with tiny variations). Mass testing forms part of the published government roadmap, out of lockdown. The government wants to buy another 280 million lfts this year. Shelley is dead on we will bag easily. That's no hunch. That's rational thinking. FFB. Try meditation?
Yeah it does show poor research don't it. I think that now they have published the latest PHE meta analysis of lfts the government will take on the argument more assertively. Better hope that there aren't any curious journalists out there who want to know about why they ****ed up so badly on this in the first place wasting time with multiple evaluations when if they had done it properly in the first place they could have come to the conclusion that some lfts are just as good as PCRs last year. As Professor Tara Moore had explained from the offset.
Yep. They are telling us. The pressure will build from here. ODX is getting ready to blow like a geyser. Hot, long, strong and higher than the mountains of Montana!
RE: inova doing more damage to lft reputation10 Mar 2021 16:42
Well it will force the conversation. Hopefully the new narrative will recognise that new generation tests are coming out any day now, that will exceed Innova's standards and that PCR tests can also produce a small number of false positives and the new tests are much less likely to produce the far more dangerous false negatives.
When we get news, ours is due first- Mologic and contract publication, I can see a lot of other cv19 investors jumping over. Anyway, I am very hungry now! Back to the kitchen for me then. Lol. GLA
Who cares Regulator? The point is they're trying. In real life things rarely get done absolutely precisely as they should do. The pressure is on the government to be seen to try. The judicial review, the opposition are demanding that contracts are published. I've been here 11 months. It's about to happen. Maybe tomorrow. Friday. Maybe next week. But it's happening and this is the time to load up if you can or hold or get in!
Are saying that the Surescreen contract was published a month after it was signed. Well 29 days afterwards to be precise. They are sharing bits and pieces. No idea how to check the veracity of it. As we have all noted they are sometimes on the money.
Cheapest covid share with real near term credibility10 Mar 2021 13:59
On the market. Cast our minds back to last Summer. The sp was lingering at £1.10. Then we were subject to the poorly managed PHE outsourced evaluation which used outdated methodology to assess the ABC19 test. Sneakily acknowledged in the EDSAB report published after hours weeks later. That's history now. The ABC19 test, fully vindicated in line with the first independent findings is getting distributors agreed for sales. We are one of 4 suppliers. We now have a government contract for antigen lfts. We are one of 3 suppliers. Capacity for 100 million. 280 million lfts yet to be purchased. An £8 billion contract on bid stats likely to be drawn down this year and next. Last chance to buy under a quid. Still a bagger in the near term from here. Load up guys and gals!
RE: Lateral flow specificity in phase 4 marketing gov.uk10 Mar 2021 13:28
Conclusion These analyses support the policy of not requiring PCRs to confirm the status of positive lateral flow tests... Job done! Bit outrageous that we have had to wait this long for this. But there we are. Just in time for Mologic's evaluation I hope.